PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson’s Disease

Parkinson’s disease (PD) is characterized mainly by the loss of dopaminergic neurons in the substantia nigra (SN) mediated via oxidative stress. Although glutaredoxin-1 (GLRX1) is known as one of the antioxidants involved in cell survival, the effects of GLRX1 on PD are still unclear. In this study,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Molecules
Autori principali: Choi, Yeon Joo, Kim, Dae Won, Shin, Min Jea, Yeo, Hyeon Ji, Yeo, Eun Ji, Lee, Lee Re, Song, Yejin, Kim, Duk-Soo, Han, Kyu Hyung, Park, Jinseu, Lee, Keun Wook, Park, Jong Kook, Eum, Won Sik, Choi, Soo Young
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8198499/
https://ncbi.nlm.nih.gov/pubmed/34206041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26113329
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi